Fund Holdings — Pivotal bioVenture Partners Investment Advisor LLC

Total Portfolio Value:
$307.79M
Total Bought:
$52.51M
Total Sold:
$35.56M
Net Transaction:
+$16.95M
Notable People:
Robert Lorne Hopfner, Peter Tuxen Bisgaard, Pivotal Bioventure Partners, Pivotal Partners Ltd
Securities
▲▼
SharesValue
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Vaxcyte, Inc.(PCVX)1,372,4251,425,470+53,045$79.75M$82.86M26.92%+$3.11M
Arcutis Biotherapeutics, Inc.(ARQT)1,355,8921,265,283-90,609$31.94M$33.18M10.78%+$1.23M
Trevi Therapeutics, Inc.(TRVI)1,553,7261,742,672+188,946$18.54M$32.50M10.56%+$13.96M
AVALYN PHARMACEUTICALS INC0966,792+966,792$0$31.83M10.34%+$31.83M
EVOMMUNE INC1,926,9431,926,9430$44.30M$25.61M8.32%-$18.69M
MAPLIGHT THERAPEUTICS INC611,447611,446-1$12.43M$21.91M7.12%+$9.48M
OCULIS HOLDING AG1,680,2831,506,250-174,033$44.68M$20.89M6.79%-$23.79M
BIOAGE LABS INC653,374653,3740$11.43M$16.01M5.20%+$4.59M
Immunome, Inc.(IMNM)732,512732,5120$16.02M$15.52M5.04%-$498.1K
Zenas BioPharma, Inc.(ZBIO)591,991490,766-101,225$11.57M$12.46M4.05%+$882.2K
AVALO THERAPEUTICS INC295,933434,033+138,100$4.42M$8.02M2.61%+$3.60M
RALLYBIO CORP300,579300,5790$2.70M$4.81M1.56%+$2.11M
Recursion Pharmaceuticals, Inc.(RXRX)595,518595,5180$1.83M$2.19M0.71%+$357.3K
BOLT BIOTHERAPEUTICS INC42,5810-42,581$172.0K$0—-$172.0K
Page 1 of 1